Data is not available for this company.
Data is not available for this company
Past 10 years financial track record analysis and assessment of future prospects by Moneyworks4me indicates that Dishman Pharmaceuticals & Chemicals Ltd. - (Amalgamated) is an average long term investment. However, you need to ensure you buy at a right price to earn good returns.
Dishman Pharmaceuticals and Chemicals Limited (DPCL) was incorporated in 1983 as a research-oriented company. Later in 1989 the company started production of a range of phase transfer catalysts and quaternary ammonium and phosphonium compounds. The company became a global market leader and earned the status of the â€œQuat Companyâ€. In the period of 10 years the production capacity was increased from 10MT per annum to 1500 Mt per annum.
In the year
In the year 1995, the company entered into a joint ventured with SchÃ¼tz & Co, Germany and formed SchÃ¼tz Dishman Biotech. This company manufactures Chlorhexidine Base, Chlorhexidine HCl, Chlorhexidine Acetate and Chlorhexidine Gluconate solution to cater European market. In 1995-96, the company expanded its activities for the development of many intermediates and APIs. In 1998 in order to penetrate in European and US market, the company formed two wholly-owned subsidiaries Dishman Europe and Dishman USA Inc. In 1998, the company forayed into contract research and manufacture sector. Within a period of 5 years DPCL was able to several contract research and manufacturing projects and later emerged as Indiaâ€™s leading CMO organization (Contract Manufacturing Outsourcing).
Headquartered at Ahmedabad, the company owns three manufacturing units, two located at Bavla and one at Naroda. Presently the company is manufactures a range of Bulk APIs, Intermediates, Specialties and Quats. The company has representative office located at Germany, Italy and Turkey.
DPCL is engaged in the manufacture of active pharmaceutical ingredients (APIs) intermediates. The Company operates in two segments: contract research and contract manufacturing (CRAMS), and bulk drugs, intermediates, quats and specialty chemicals. It provides a range of products to the global market, including a range of reagents, specialty chemicals, APIs and their intermediates.
Dishman Specialty Chemicals, which manufactures Phase Transfer Catalysts;
Dishman Vitamins and Chemicals, which manufactures Vitamin D2, Vitamin D3, Vitamin D analogues, cholesterol and laolin related products for pharmaceutical, cosmetic and related markets,
Dishman Disinfectants, which manufactures antiseptic and disinfectant formulations.
The products manufactured by the company include bulk drugs, phase transfer catalyst and fine chemicals